1. Home
  2. STRZ vs TNXP Comparison

STRZ vs TNXP Comparison

Compare STRZ & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRZ
  • TNXP
  • Stock Information
  • Founded
  • STRZ 1997
  • TNXP 2007
  • Country
  • STRZ United States
  • TNXP United States
  • Employees
  • STRZ N/A
  • TNXP N/A
  • Industry
  • STRZ
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRZ
  • TNXP Health Care
  • Exchange
  • STRZ NYSE
  • TNXP Nasdaq
  • Market Cap
  • STRZ 264.4M
  • TNXP 272.0M
  • IPO Year
  • STRZ N/A
  • TNXP N/A
  • Fundamental
  • Price
  • STRZ $16.31
  • TNXP $37.23
  • Analyst Decision
  • STRZ Strong Buy
  • TNXP Strong Buy
  • Analyst Count
  • STRZ 2
  • TNXP 2
  • Target Price
  • STRZ $26.00
  • TNXP $585.00
  • AVG Volume (30 Days)
  • STRZ 212.9K
  • TNXP 746.5K
  • Earning Date
  • STRZ 01-01-0001
  • TNXP 08-15-2025
  • Dividend Yield
  • STRZ N/A
  • TNXP N/A
  • EPS Growth
  • STRZ N/A
  • TNXP N/A
  • EPS
  • STRZ N/A
  • TNXP N/A
  • Revenue
  • STRZ $1,369,600,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • STRZ N/A
  • TNXP $11.66
  • Revenue Next Year
  • STRZ N/A
  • TNXP $793.18
  • P/E Ratio
  • STRZ N/A
  • TNXP N/A
  • Revenue Growth
  • STRZ N/A
  • TNXP N/A
  • 52 Week Low
  • STRZ $8.00
  • TNXP $6.76
  • 52 Week High
  • STRZ $22.98
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • STRZ N/A
  • TNXP 52.62
  • Support Level
  • STRZ N/A
  • TNXP $33.30
  • Resistance Level
  • STRZ N/A
  • TNXP $36.33
  • Average True Range (ATR)
  • STRZ 0.00
  • TNXP 2.79
  • MACD
  • STRZ 0.00
  • TNXP -0.60
  • Stochastic Oscillator
  • STRZ 0.00
  • TNXP 59.69

About STRZ STARZ ENTERTAINMENT CORP

Starz Entertainment Corp is the premium entertainment destination for women and underrepresented audiences, and home to some of the popular franchises and series on television. It offers a robust programming mix for discerning adult audiences, including boundary-breaking originals and an expansive lineup of blockbuster movies, and is embodied by its brand positioning, We're All Adults Here. Complementary to any platform or service, it is available across a wide range of digital OTT platforms and multichannel video distributors and is a bundling partner of choice. STARZ is powered by an industry-leading technology, data analytics, and digital infrastructure, and the highly rated and first-of-its-kind STARZ app.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: